A Study To Evaluate At-Home Monitoring Of Patients With Decompensated Cirrhosis

Overview

About this study

The purpose of this study is to determine if there is a correlation between patient quality of life and rate of hospital readmission in patients hospitalized with decompensated cirrhosis. The REMODI program has already been implemented in the department of medicine at Mayo to monitor subjects via mobile devices after discharge from the hospital. We aim to determine the impact of these interventions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects over the age of 18 years.

  • Ability to provide written, informed consent.

  • Hospitalized with complications of decompensated cirrhosis.

Exclusion Criteria: 

  • Subjects under 18 years of age.

  • Subject has uncontrolled mental illness and/or drug or alcohol abuse.

  • Resides in (or is discharging to) a long-term care facility.

  • Subject is being actively followed by dialysis or transplant services.

  • Subject is pregnant.

  • Subject is being actively treated for cancer.

  • Subject is identified as end of life by provider.

  • Subject has dementia, cognitive impairment, or physical condition that limits ability to use home remote monitoring equipment independently, or interact with remote patient monitoring staff (unless a caregiver commits to assisting daily).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 05/07/2021. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Douglas Simonetto, M.D.

Open for enrollment

Contact information:

Douglas Simonetto M.D.

(507) 284-1649

Simonetto.Douglas@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Douglas Simonetto, M.D.

Contact us for the latest status

Contact information:

Daniel Penrice M.D.

Penrice.Daniel@mayo.edu

More information

Publications

Publications are currently not available